Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;22(11):5533-5538.
doi: 10.1111/jcmm.13827. Epub 2018 Aug 29.

Identification of a GNE homozygous mutation in a Han-Chinese family with GNE myopathy

Yuan Wu  1   2 , Lamei Yuan  1 , Yi Guo  1   3 , Anjie Lu  4 , Wen Zheng  5 , Hongbo Xu  1 , Yan Yang  5 , Pengzhi Hu  6 , Shaojuan Gu  5 , Bingqi Wang  1 , Hao Deng  1
Affiliations

Identification of a GNE homozygous mutation in a Han-Chinese family with GNE myopathy

Yuan Wu et al. J Cell Mol Med. 2018 Nov.

Abstract

GNE myopathy is a rare, recessively inherited, early adult-onset myopathy, characterized by distal and proximal muscle degeneration which often spares the quadriceps. It is caused by mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene (GNE). This study aimed to identify the disease-causing mutation in a three-generation Han-Chinese family with members who have been diagnosed with myopathy. A homozygous missense mutation, c.1627G>A (p.V543M) in the GNE gene co-segregates with the myopathy present in this family. A GNE myopathy diagnosis is evidenced by characteristic clinical manifestations, rimmed vacuoles in muscle biopsies and the presence of biallelic GNE mutations. This finding broadens the GNE gene mutation spectrum and extends the GNE myopathy phenotype spectrum.

Keywords: GNE myopathy; homozygous; missense mutation; the GNE gene.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree data of a GNE myopathy family. A, Pedigree of the family with GNE myopathy. N: normal; M: the GNE c.1627G>A (p.V543M) mutation. Arrow indicates the proband. B, Sequence of homozygous c.1627G>A (p.V543M) variant. C, Sequence of heterozygous c.1627G>A (p.V543M) variant. D, Sequence of a normal control
Figure 2
Figure 2
MRI in patients (II:3 and II:5) revealed serious fatty replacement in posterior and medial compartments of the thigh muscles and almost all lower leg muscles, which also presented in the buttock muscles of the patient (II:3). (A and B), axial T1‐weighted and axial PDw SPAIR MRI of thigh, lower leg and buttock muscles in patient (II:3). (C and D), axial T1‐weighted and axial PDw SPAIR MRI of thigh and lower leg muscles in patient (II:5)
Figure 3
Figure 3
Conservation analysis of the GNE p.Val543 amino acid residue
See this image and copyright information in PMC

References

    1. Celeste FV, Vilboux T, Ciccone C, et al. Mutation update for GNE gene variants associated with GNE myopathy. Hum Mutat. 2014;35:915‐926. - PMC - PubMed
    1. Zhao J, Wang Z, Hong D, et al. Mutational spectrum and clinical features in 35 unrelated mainland Chinese patients with GNE myopathy. J Neurol Sci. 2015;354:21‐26. - PubMed
    1. Mori‐Yoshimura M, Hayashi YK, Yonemoto N, et al. Nationwide patient registry for GNE myopathy in Japan. Orphanet J Rare Dis. 2014;9:150. - PMC - PubMed
    1. Nishino I, Carrillo‐Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry. 2015;86:385‐392. - PMC - PubMed
    1. No D, Valles‐Ayoub Y, Carbajo R, et al. Novel GNE mutations in autosomal recessive hereditary inclusion body myopathy patients. Genet Test Mol Biomarkers. 2013;17:376‐382. - PubMed

Publication types

Substances

Supplementary concepts